Grants and Contracts
Congratulations to the following individuals for obtaining extramural funding from federal, state, and/or independent sources between November 1, 2022 and January 31, 2023!
NOTE: If any information has been inadvertently omitted, please contact the editor (dflock@lsuhsc.edu) and the information will be included in the next issue of The Pulse.
National Institutes of Health (R01):
Jennifer Lentz, PhD (Neuroscience Center of Excellence)
“Vestibular Dysfunction and the Development of Therapies for Usher Syndrome”
Bolin Liu, MD (Genetics)
“Signaling Axis in Triple-negative Breast Cancer Progression”
Yaguang Xi, MD, PhD, MBA (Genetics)
“Interactions between ES-miRNAs and Environmental Risk Factors are Responsible for
TNBC Progression and Associated Racial Health Disparities: A Novel Analysis with Multilevel
Moderation Inferences”
National Institutes of Health:
Dr. Aline Zaparte (Pulmonary and ADACE)
LAUNCHED Pilot and Feasibility Grant
University Collaborations:
Louisiana Cancer Research Center
Pinki Prasad, MD (Pediatrics)
"Improving Oncofertility Care and Referrals through Implementation of a Risk Stratification
System for Adolescents and Young Adults at NCORP-MU"
LSU Collaborative Cancer Research Initiative (CCRI)
Michael Lan, PhD (Pediatrics)
“Targeting INSMI for the Treatment of Neuroendocrine Prostate Cancer”
LSU Collaborative Cancer Research Initiative (CCRI)
Samarpan Majumder, PhD (Genetics)
“Modulating Gut Microbiome to Enhance the Efficacy of Immunotherapy”
LSU Collaborative Cancer Research Initiative (CCRI)
Michael Dunham, MD (Department of Otolaryngology)
“Intraoperatively Detecting and Diagnosing Laryngeal Cancer by Machine-learning”
LSU Collaborative Cancer Research Initiative (CCRI)
Bolin Liu, MD (Genetics)
“Reposition of the Fungicide Ciclopirox for Triple Negative Breast Cancer Therapy”
LSU Collaborative Cancer Research Initiative (CCRI)
Krzysztof Reiss, PhD (Stanley S. Scott Cancer Center)
“New Anti-glioblastoma Metabolic Compounds with High Potential for Blood Brain Barrier”
LSU Collaborative Cancer Research Initiative (CCRI)
Maria Sanchez-Pino, PhD (Genetics)
“Effects of Metabolic Surgery on Lipid Metabolism, MDSC and Cancer Cell Biology”
LSU Collaborative Cancer Research Initiative (CCRI)
Qiang Shen, MD, PhD (Genetics)
“Oncogenic Role of mitoNEET”
LSU Collaborative Cancer Research Initiative (CCRI)
Martin Ronis, PhD (Pharmacology; Co-PI)
“The Role of Mitochondrial Efficiency in NASH-related Hepatocellular Carcinoma (HCC),
the Most Common Primary Liver Cancer”
Pharmaceutical and Company Grants:
Juzar Ali, MD (Medicine, Pulmonary/Critical Care)
Medpace, Inc.
“A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective
Study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered
Epetraborole in Patients With Treatment-refractory Mycobacterium Avium Complex Lung
Disease”
Brian Copeland, MD (Neurology)
Parexel International Corp
"A Multicentre, Interventional, Post-marketing, Randomized, Double-blind, Crossover
Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport®)
in Comparison with OnabotulinumtoxinA (Botox®) when Treating Adults with Upper Limb
Spasticity”
Alison Smith, MD, PhD (Physiology) and Jeff Hobden, PhD (Microbiology, Immunology
& Parasitology)
3M Corporation
"Use of V.A.C. VERAFLO to Deliver Pro-Healing and Anti-Infective Agents in an Acute
Porcine Model of Surgical Wounds"
Rebecca Lillis, MD (Medicine/Infectious Diseases)
BioFire Diagnostics, LLC
“Evaluation of Accuracy and Ease of Use of the BioFire -Sexually Transmitted Infection
Panel on the BioFire SpotFire System in a Near-Patient Setting”
Rebecca Lillis, MD (Medicine/Infectious Diseases)
Roche Molecular Systems, Inc.
“Evaluating the cobas® CT/NG/MG Nucleic Acid Test for Use on the cobas® Liat® System:
Clinical Performance Evaluation”
Stephen Lindsey, MD (Medicine/Rheumatology)
Priovant-Premier PVT
“A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study to Investigate the
Efficacy and Safety of Oral Brepocitinib in Adults with Dermatomyositis”